Patent · US Active

Tissue regeneration

US7854944B2 · kind B2 · utility

12Cited by
67References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 17, 2004
Grant dateDec 21, 2010
Priority date
Expiry dateOct 19, 2026

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61L2300/622
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

A method including positioning a delivery device at a location in a vessel within a mammalian body, introducing a first treatment agent including a cellular component through the delivery device, and introducing a different second treatment agent disposed in a carrier through the delivery device. A method including identifying an infarct region within myocardial tissue and a border region of perfused tissue adjacent the infarct region, introducing a treatment agent including a cellular component to the border region, and introducing a plurality of microparticles to the infarct region. A kit including a treatment agent including a cellular component in a form suitable for percutaneous delivery, and a separate amount of a plurality of microparticles in a form suitable for percutaneous delivery.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.